Drug Shortage Report for AMINOSYN II

Last updated on 2018-11-29 History
Report ID 41252
Drug Identification Number 02126745
Brand name AMINOSYN II
Common or Proper name Aminosyn™ II 15% Amino Acid for Injection (Sulfite-free)
Company Name ICU MEDICAL CANADA INC
Market Status DORMANT
Active Ingredient(s) HISTIDINE TRYPTOPHAN N-ACETYL-L-TYROSINE L-LYSINE L-ALANINE METHIONINE GLYCINE GLUTAMIC ACID L-PROLINE L-ARGININE L-VALINE L-ASPARTIC ACID L-THREONINE L-PHENYLALANINE L-LEUCINE L-ISOLEUCINE SERINE
Strength(s) 450MG 300MG 405MG 1.575G 1.49G 258MG 750MG 1.107G 1.083G 1.527G 750MG 1.05G 600MG 447MG 1.5G 990MG 795MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2000ML
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-06-05
Actual start date 2017-06-05
Estimated end date 2019-01-31
Actual end date 2018-10-31
Shortage status Resolved
Updated date 2018-11-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2600 BOUL ALFRED-NOBEL, SUITE 100
SAINT LAURENT, QUEBEC
CANADA H4S 0A9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-02-27 English Compare
v2 2018-02-27 French Compare
v3 2018-04-23 English Compare
v4 2018-04-23 French Compare
v5 2018-05-28 English Compare
v6 2018-05-28 English Compare
v7 2018-05-28 French Compare
v8 2018-11-29 English Compare
v9 2018-11-29 French Compare

Showing 1 to 9 of 9